No Data
Investor Optimism Abounds Bluebird Bio, Inc. (NASDAQ:BLUE) But Growth Is Lacking
Bluebird Bio Trading Halted, News Pending
Express News | Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
Bluebird Bio To Carry Out 1-for-20 Reverse Stock Split On December 13th, 2024
Reported Sunday, Bluebird Bio Highlights 9-Year Data For LYFGENIA Gene Therapy: Sustained Benefits In Sickle Cell Disease Patients At ASH 2024
Bluebird Bio Announced Long-Term Follow-Up Data Continue To Support Beti-Cel As Potentially Curative Gene Therapy For Β-Thalassemia Patients Who Require Regular Transfusions Through Achievement Of Durable Transfusion Independence And Normal Or...
HannChau : any thought on BCTX?
Jaguar8 OP HannChau : I’m hoping it will recover too since it closed its offering today
HannChau Jaguar8 OP : haha, i went in again. I think it will go back to 1 soon
S2ET0 HannChau : 我還在1.04
Jaguar8 OP HannChau : I’ll just re-enter PM hoping no offering is announce over the weekend
View more comments...